Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Cancer immunotherapy of human papillomavirus-induced (pre)malignant lesion using replication-incompetent Semliki Forest Virus replicon particles encoding human papillomavirus antigens.

Proposed period of release:
01/01/2012 to 01/01/2022

Name of the Institute(s) or Company(ies)
University Medical Center Groningen, Hanzeplein 1
9713 GZ Groningen
PO Box 30.001
9700 RB Groningen
The Netherlands;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Togaviruses, Genus Alphavirus, Semliki Forest virus (SFV)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
SFVAlphavirusesSemliki Forest virus-SFV L10-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known